Mountain View, CALIFORNIA3 Active Studies

Diabetic Retinopathy Clinical Trials in Mountain View, CALIFORNIA

Find 3 actively recruiting diabetic retinopathy clinical trials in Mountain View, CALIFORNIA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
2,140
Enrolling

Recruiting Diabetic Retinopathy Studies in Mountain View

About Diabetic Retinopathy Clinical Trials in Mountain View

Diabetic retinopathy is a diabetes complication that affects the blood vessels in the retina and is the leading cause of blindness in working-age adults. Diabetic macular edema (DME) involves fluid accumulation in the macula. Treatment includes anti-VEGF injections, laser therapy, and blood sugar control.

There are currently 3 diabetic retinopathy clinical trials recruiting participants in Mountain View, CALIFORNIA. These studies are seeking a combined 2,140 participants. Research is being sponsored by EyeBiotech Ltd., Hoffmann-La Roche, Genentech, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Diabetic Retinopathy Clinical Trials in Mountain View — FAQ

Are there diabetic retinopathy clinical trials in Mountain View?

Yes, there are 3 diabetic retinopathy clinical trials currently recruiting in Mountain View, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Mountain View?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Mountain View research site will contact you about next steps.

Are clinical trials in Mountain View free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Mountain View studies also compensate for your time and travel.

What diabetic retinopathy treatments are being tested?

The 3 active trials in Mountain View are testing new therapies including novel drugs, biologics, and treatment approaches for diabetic retinopathy.

Data updated March 2, 2026 from ClinicalTrials.gov